Shareholder rights law firm Robbins LLP is investigating Talis Biomedical Corporation (NASDAQ: TLIS) to determine whether certain Talis officers and directors violated securities laws and breached fiduciary...
Conference call and webcast today at 4:30pm Eastern/1:30pm Pacific...
TLIS earnings call for the period ending March 31, 2022.
MENLO PARK, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to advancing health equity and outcomes...
TLIS earnings call for the period ending December 31, 2021.
Conference call and webcast today at 4:30pm Eastern/1:30pm Pacific...
MENLO PARK, Calif., March 01, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to advancing health equity and outcomes...